Genetic Manipulation of Cell Death and Neuroplasticity Pathways in Traumatic Brain Injury

Neurotherapeutics

Volumn 9, Issue 2, 2012, Pages 323-337

  Schoch, Kathleen M ^a   Madathil, Sindhu K ^a   Saatman, Kathryn E ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Apoptosis; Growth factors; Knockout mice; Neurogenesis; Neuroplasticity; Transgenic mice

Indexed keywords

CASPASE; CASPASE 3; CASPASE 8; CASPASE ACTIVATED DEOXYRIBONUCLEASE; CELL CYCLE PROTEIN; CYCLIN D1; EPHRIN; FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON RECEPTOR 1; MITOGENIC AGENT; NEUROTROPHIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BID; PROTEIN NOGO A; PROTEIN P53;

APOPTOSIS; ASTROCYTOSIS; BRAIN SIZE; CELL CYCLE PROGRESSION; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CONVALESCENCE; DENTATE GYRUS; DNA FRAGMENTATION; ENZYME ACTIVATION; GENE DELETION; GENE INACTIVATION; GENETIC MANIPULATION; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; HUMAN; KNOCKOUT MOUSE; MITOGENESIS; NERVE CELL NECROSIS; NERVE CELL PLASTICITY; NERVE DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEM CELL; TRANSGENIC MOUSE; TRAUMATIC BRAIN INJURY;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BRAIN INJURIES; CELL DEATH; GENE KNOCKDOWN TECHNIQUES; GENETIC TECHNIQUES; HUMANS; NEURONAL PLASTICITY; SIGNAL TRANSDUCTION;

EID: 84859728162     PISSN: 19337213     EISSN: 18787479     Source Type: Journal    
DOI: 10.1007/s13311-012-0107-z     Document Type: Review

References (122)

1. Maas AI, Roozenbeek B, Manley GT. Clinical trials in traumatic brain injury: past experience and current developments. Neurotherapeutics 2010; 7: 115-126.
2. Hall ED, Sullivan PG, Gibson TR, et al. Spatial and temporal characteristics of neurodegeneration after controlled cortical impact in mice: more than a focal brain injury. J Neurotrauma 2005; 22: 252-265.
3. Saatman KE, Feeko KJ, Pape RL, Raghupathi R. Differential behavioral and histopathological responses to graded cortical impact injury in mice. J Neurotrauma 2006; 23: 1241-1253.
4. Fox GB, LeVasseur RA, Faden AI. Behavioral responses of C57BL/6, FVB/N, and 129/SvEMS mouse strains to traumatic brain injury: implications for gene targeting approaches to neurotrauma. J Neurotrauma 1999; 16: 377-389.
5. Smith DH, Soares HD, Pierce JS, et al. A model of parasagittal controlled cortical impact in the mouse: cognitive and histopathologic effects. J Neurotrauma 1995; 12: 169-178.
6. Longhi L, Saatman KE, Raghupathi R, et al. A review and rationale for the use of genetically engineered animals in the study of traumatic brain injury. J Cereb Blood Flow Metab 2001; 21: 1241-1258.
7. Raghupathi R. Cell death mechanisms following traumatic brain injury. Brain Pathol 2004; 14: 215-222.
8. Sutton RL, Lescaudron L, Stein DG. Unilateral cortical contusion injury in the rat: vascular disruption and temporal development of cortical necrosis. J Neurotrauma 1993; 10: 135-149.
9. Sullivan PG, Keller JN, Bussen WL, Scheff SW. Cytochrome c release and caspase activation after traumatic brain injury. Brain Res 2002; 949: 88-96.
10. Newcomb JK, Zhao X, Pike BR, Hayes RL. Temporal profile of apoptotic-like changes in neurons and astrocytes following controlled cortical impact injury in the rat. Exp Neurol 1999; 158: 76-88.
11. Luo CL, Li BX, Li QQ, et al. Autophagy is involved in traumatic brain injury-induced cell death and contributes to functional outcome deficits in mice. Neuroscience 2011; 184: 54-63.
12. Sadasivan S, Dunn WA Jr., Hayes RL, Wang KK. Changes in autophagy proteins in a rat model of controlled cortical impact induced brain injury. Biochem Biophys Res Commun 2008; 373: 478-481.
13. Liu CL, Chen S, Dietrich D, Hu BR. Changes in autophagy after traumatic brain injury. J Cereb Blood Flow Metab 2008; 28: 674-683.
14. Clark RS, Kochanek PM, Dixon CE, et al. Early neuropathologic effects of mild or moderate hypoxemia after controlled cortical impact injury in rats. J Neurotrauma 1997; 14: 179-189.
15. Colicos MA, Dash PK. Apoptotic morphology of dentate gyrus granule cells following experimental cortical impact injury in rats: possible role in spatial memory deficits. Brain Res 1996; 739: 120-131.
16. Rink A, Fung KM, Trojanowski JQ, et al. Evidence of apoptotic cell death after experimental traumatic brain injury in the rat. Am J Pathol 1995; 147: 1575-1583.
17. Beer R, Franz G, Schopf M, et al. Expression of Fas and Fas ligand after experimental traumatic brain injury in the rat. J Cereb Blood Flow Metab 2000; 20: 669-677.
18. Cernak I, Chapman SM, Hamlin GP, Vink R. Temporal characterisation of pro- and anti-apoptotic mechanisms following diffuse traumatic brain injury in rats. J Clin Neurosci 2002; 9: 565-572.
19. Clark RS, Chen J, Watkins SC, et al. Apoptosis-suppressor gene bcl-2 expression after traumatic brain injury in rats. J Neuroscience 1997; 17: 9172-9182.
20. Keane RW, Kraydieh S, Lotocki G, et al. Apoptotic and antiapoptotic mechanisms after traumatic brain injury. J Cereb Blood Flow Metab 2001; 21: 1189-1198.
21. Knoblach SM, Nikolaeva M, Huang X, et al. Multiple caspases are activated after traumatic brain injury: evidence for involvement in functional outcome. J Neurotrauma 2002; 19: 1155-1170.
22. Larner SF, McKinsey DM, Hayes RL, KK WW. Caspase 7: increased expression and activation after traumatic brain injury in rats. J Neurochem 2005; 94: 97-108.
23. Qiu J, Whalen MJ, Lowenstein P, et al. Upregulation of the Fas receptor death-inducing signaling complex after traumatic brain injury in mice and humans. J Neuroscience 2002; 22: 3504-3511.
24. Larner SF, Hayes RL, McKinsey DM, Pike BR, Wang KK. Increased expression and processing of caspase-12 after traumatic brain injury in rats. J Neurochem 2004; 88: 78-90.
25. Clark RS, Kochanek PM, Chen M, et al. Increases in Bcl-2 and cleavage of caspase-1 and caspase-3 in human brain after head injury. FASEB J 1999; 13: 813-821.
26. Clark RS, Kochanek PM, Adelson PD, et al. Increases in bcl-2 protein in cerebrospinal fluid and evidence for programmed cell death in infants and children after severe traumatic brain injury. J Pediatr 2000; 137: 197-204.
27. Darwish RS, Amiridze NS. Detectable levels of cytochrome C and activated caspase-9 in cerebrospinal fluid after human traumatic brain injury. Neurocrit Care 2010; 12: 337-341.
28. Satchell MA, Lai Y, Kochanek PM, et al. Cytochrome c, a biomarker of apoptosis, is increased in cerebrospinal fluid from infants with inflicted brain injury from child abuse. J Cereb Blood Flow Metab 2005; 25: 919-927.
29. Harter L, Keel M, Hentze H, Leist M, Ertel W. Caspase-3 activity is present in cerebrospinal fluid from patients with traumatic brain injury. J Neuroimmunol 2001; 121: 76-78.
30. Clark RS, Nathaniel PD, Zhang X, et al. boc-Aspartyl(OMe)-fluoromethylketone attenuates mitochondrial release of cytochrome c and delays brain tissue loss after traumatic brain injury in rats. J Cereb Blood Flow Metab 2007; 27: 316-326.
31. Fink KB, Andrews LJ, Butler WE, et al. Reduction of post-traumatic brain injury and free radical production by inhibition of the caspase-1 cascade. Neuroscience 1999; 94: 1213-1218.
32. Knoblach SM, Alroy DA, Nikolaeva M, et al. Caspase inhibitor z-DEVD-fmk attenuates calpain and necrotic cell death in vitro and after traumatic brain injury. J Cereb Blood Flow Metab 2004; 24: 1119-1132.
33. Franz G, Beer R, Intemann D, et al. Temporal and spatial profile of Bid cleavage after experimental traumatic brain injury. J Cereb Blood Flow Metab 2002; 22: 951-958.
34. Raghupathi R, Strauss KI, Zhang C, et al. Temporal alterations in cellular Bax: Bcl-2 ratio following traumatic brain injury in the rat. J Neurotrauma 2003; 20: 421-435.
35. Wennersten A, Holmin S, Mathiesen T. Characterization of Bax and Bcl-2 in apoptosis after experimental traumatic brain injury in the rat. Acta Neuropathol 2003; 105: 281-288.
36. Bermpohl D, You Z, Korsmeyer SJ, Moskowitz MA, Whalen MJ. Traumatic brain injury in mice deficient in Bid: effects on histopathology and functional outcome. J Cereb Blood Flow Metab 2006; 26: 625-633.
37. Shi J, Miles DK, Orr BA, Massa SM, Kernie SG. Injury-induced neurogenesis in Bax-deficient mice: evidence for regulation by voltage-gated potassium channels. The Eur J Neurosci 2007; 25: 3499-3512.
38. Tehranian R, Rose ME, Vagni V, et al. Disruption of Bax protein prevents neuronal cell death but produces cognitive impairment in mice following traumatic brain injury. J Neurotrauma 2008; 25: 755-767.
39. Wolf BB, Schuler M, Echeverri F, Green DR. Caspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor-45/inhibitor of caspase-activated DNase inactivation. J Biol Chem 1999; 274: 30651-30656.
40. Enari M, Sakahira H, Yokoyama H, et al. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998; 391: 43-50.
41. Liu X, Li P, Widlak P, et al. The 40-kDa subunit of DNA fragmentation factor induces DNA fragmentation and chromatin condensation during apoptosis. Proc Natl Acad Sci U S A 1998; 95: 8461-8466.
42. Liu X, Zou H, Slaughter C, Wang X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 1997; 89: 175-184.
43. Zhang C, Raghupathi R, Saatman KE, LaPlaca MC, McIntosh TK. Regional and temporal alterations in DNA fragmentation factor (DFF)-like proteins following experimental brain trauma in the rat. J Neurochem 1999; 73: 1650-1659.
44. Yakovlev AG, Di X, Movsesyan V, et al. Presence of DNA fragmentation and lack of neuroprotective effect in DFF45 knockout mice subjected to traumatic brain injury. Mol Med 2001; 7: 205-216.
45. Krajewska M, You Z, Rong J, et al. Neuronal deletion of caspase 8 protects against brain injury in mouse models of controlled cortical impact and kainic acid-induced excitotoxicity. PloS one 2011; 6: e24341.
46. Beer R, Franz G, Krajewski S, et al. Temporal and spatial profile of caspase 8 expression and proteolysis after experimental traumatic brain injury. J Neurochem 2001; 78: 862-873.
47. Zhang X, Graham SH, Kochanek PM, et al. Caspase-8 expression and proteolysis in human brain after severe head injury. FASEB J 2003; 17: 1367-1369.
48. Raghupathi R, Conti AC, Graham DI, et al. Mild traumatic brain injury induces apoptotic cell death in the cortex that is preceded by decreases in cellular Bcl-2 immunoreactivity. Neuroscience 2002; 110: 605-616.
49. Strauss KI, Narayan RK, Raghupathi R. Common patterns of bcl-2 family gene expression in two traumatic brain injury models. Neurotox Res 2004; 6: 333-342.
50. Bailly-Maitre B, Fondevila C, Kaldas F, et al. Cytoprotective gene bi-1 is required for intrinsic protection from endoplasmic reticulum stress and ischemia-reperfusion injury. Proc Natl Acad Sci U S A 2006; 103: 2809-2814.
51. Raghupathi R, Fernandez SC, Murai H, et al. BCL-2 overexpression attenuates cortical cell loss after traumatic brain injury in transgenic mice. J Cereb Blood Flow Metab 1998; 18: 1259-1269.
52. Nakamura M, Raghupathi R, Merry DE, et al. Overexpression of Bcl-2 is neuroprotective after experimental brain injury in transgenic mice. J Comp Neurol 1999; 412: 681-692.
53. Tehranian R, Rose ME, Vagni V, et al. Transgenic mice that overexpress the anti-apoptotic Bcl-2 protein have improved histological outcome but unchanged behavioral outcome after traumatic brain injury. Brain Res 2006; 1101: 126-135.
54. Krajewska M, Xu L, Xu W, et al. Endoplasmic reticulum protein BI-1 modulates unfolded protein response signaling and protects against stroke and traumatic brain injury. Brain Res 2011; 1370: 227-237.
55. Yu SW, Wang H, Poitras MF, et al. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 2002; 297: 259-263.
56. Cregan SP, Dawson VL, Slack RS. Role of AIF in caspase-dependent and caspase-independent cell death. Oncogene 2004; 23: 2785-2796.
57. Kroemer G, Martin SJ. Caspase-independent cell death. Nat Med 2005; 11: 725-730.
58. Cande C, Vahsen N, Kouranti I, et al. AIF and cyclophilin A cooperate in apoptosis-associated chromatinolysis. Oncogene 2004; 23: 1514-1521.
59. Hutchison JS, Derrane RE, Johnston DL, et al. Neuronal apoptosis inhibitory protein expression after traumatic brain injury in the mouse. J Neurotrauma 2001; 18: 1333-1347.
60. LaPlaca MC, Raghupathi R, Verma A, et al. Temporal patterns of poly(ADP-ribose) polymerase activation in the cortex following experimental brain injury in the rat. J Neurochem 1999; 73: 205-213.
61. Zhang X, Chen J, Graham SH, et al. Intranuclear localization of apoptosis-inducing factor (AIF) and large scale DNA fragmentation after traumatic brain injury in rats and in neuronal cultures exposed to peroxynitrite. J Neurochem 2002; 82: 181-191.
62. Whalen MJ, Clark RS, Dixon CE, et al. Reduction of cognitive and motor deficits after traumatic brain injury in mice deficient in poly(ADP-ribose) polymerase. J Cereb Blood Flow Metab 1999; 19: 835-842.
63. Satoh MS, Poirier GG, Lindahl T. NAD(+)-dependent repair of damaged DNA by human cell extracts. J Biol Chem 1993; 268: 5480-5487.
64. Slemmer JE, Zhu C, Landshamer S, et al. Causal role of apoptosis-inducing factor for neuronal cell death following traumatic brain injury. Am J Pathol 2008; 173: 1795-1805.
65. Redell JB, Zhao J, Dash PK. Acutely increased cyclophilin a expression after brain injury: a role in blood-brain barrier function and tissue preservation. J Neurosci Res 2007; 85: 1980-1988.
66. Zhu C, Wang X, Deinum J, et al. Cyclophilin A participates in the nuclear translocation of apoptosis-inducing factor in neurons after cerebral hypoxia-ischemia. J Exp Med. 2007; 204: 1741-1748.
67. Piao C, Loane D, Li S, et al. Additive neuroprotection by combined inhibition of caspase- and AIF-dependent cell death pathways after controlled cortical impact injury in mice. Program No. 363. 18. 2011 Neuroscience Meeting Planner. Washington, DC: Society for Neuroscience, 2011. Online.
68. Napieralski JA, Raghupathi R, McIntosh TK. The tumor-suppressor gene, p53, is induced in injured brain regions following experimental traumatic brain injury. Brain Res Mol Brain Res 1999; 71: 78-86.
69. Kaya SS, Mahmood A, Li Y, et al. Apoptosis and expression of p53 response proteins and cyclin D1 after cortical impact in rat brain. Brain Res 1999; 818: 23-33.
70. Kabadi SV, Stoica BA, Byrnes KR, et al. Selective CDK inhibitor limits neuroinflammation and progressive neurodegeneration after brain trauma. J Cereb Blood Flow Metab 2011; 32: 137-149.
71. Di Giovanni S, Movsesyan V, Ahmed F, et al. Cell cycle inhibition provides neuroprotection and reduces glial proliferation and scar formation after traumatic brain injury. Proc Nat Acad Sci U S A 2005; 102: 8333-8338.
72. Tomasevic G, Raghupathi R, Scherbel U, Wieloch T, McIntosh TK. Deletion of the p53 tumor suppressor gene improves neuromotor function but does not attenuate regional neuronal cell loss following experimental brain trauma in mice. J Neurosci Res 2010; 88: 3414-3423.
73. Kabadi SV, Stoica BA, Loane DJ, et al. Cyclin D1 Gene Ablation Confers Neuroprotection in Traumatic Brain Injury. J Neurotrauma 2011; doi: 10. 1089/neu. 2011. 1980.
74. Thau-Zuchman O, Shohami E, Alexandrovich AG, Leker RR. Vascular endothelial growth factor increases neurogenesis after traumatic brain injury. J Cereb Blood Flow Metab 2010; 30: 1008-1016.
75. Kernie SG, Erwin TM, Parada LF. Brain remodeling due to neuronal and astrocytic proliferation after controlled cortical injury in mice. J Neurosci Res 2001; 66: 317-326.
76. Lee C, Agoston DV. Vascular endothelial growth factor is involved in mediating increased de novo hippocampal neurogenesis in response to traumatic brain injury. J Neurotrauma 2010; 27: 541-553.
77. Farmer J, Zhao X, van Praag H, et al. Effects of voluntary exercise on synaptic plasticity and gene expression in the dentate gyrus of adult male Sprague-Dawley rats in vivo. Neuroscience 2004; 124: 71-79.
78. Imayoshi I, Sakamoto M, Ohtsuka T, et al. Roles of continuous neurogenesis in the structural and functional integrity of the adult forebrain. Nat Neurosci 2008; 11: 1153-1161.
79. Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol 2010; 119: 7-35.
80. Myer DJ, Gurkoff GG, Lee SM, Hovda DA, Sofroniew MV. Essential protective roles of reactive astrocytes in traumatic brain injury. Brain. 2006; 129: 2761-2772.
81. Kernie SG, Parent JM. Forebrain neurogenesis after focal Ischemic and traumatic brain injury. Neurobiol Dis 2010; 37: 267-274.
82. Alvarez-Buylla A, Lim DA. For the long run: maintaining germinal niches in the adult brain. Neuron 2004; 41: 683-686.
83. Kempermann G, Jessberger S, Steiner B, Kronenberg G. Milestones of neuronal development in the adult hippocampus. Trends Neurosci 2004; 27: 447-452.
84. Kronenberg G, Reuter K, Steiner B, et al. Subpopulations of proliferating cells of the adult hippocampus respond differently to physiologic neurogenic stimuli. J Comp Neurol 2003; 467: 455-463.
85. Mignone J, Kukekiv V, Chiang A, Steindler D, Enikolopov G. Neural stem and progenitor cells in Nestin-GFP transgenic mice. J Comp Neurol 2004; 469: 311-324.
86. Yu TS, Zhang G, Liebl DJ, Kernie SG. Traumatic brain injury-induced hippocampal neurogenesis requires activation of early nestin-expressing progenitors. J Neurosci 2008; 28: 12901-12912.
87. Blaiss CA, Yu TS, Zhang G, et al. Temporally specified genetic ablation of neurogenesis impairs cognitive recovery after traumatic brain injury. J Neurosci 2011; 31: 4906-4916.
88. Lau BW, Yau SY, Lee TM, et al. Intracerebroventricular infusion of cytosine-arabinoside causes prepulse inhibition disruption. Neuroreport 2009; 20: 371-377.
89. Hellstrom NA, Bjork-Eriksson T, Blomgren K, Kuhn HG. Differential recovery of neural stem cells in the subventricular zone and dentate gyrus after ionizing radiation. Stem Cells 2009; 27: 634-641.
90. Noonan MA, Bulin SE, Fuller DC, Eisch AJ. Reduction of adult hippocampal neurogenesis confers vulnerability in an animal model of cocaine addiction. J Neurosci 2010; 30: 304-315.
91. Barde YA. Trophic factors and neuronal survival. Neuron 1989; 2: 1525-1534.
92. Barnabe-Heider F, Miller FD. Endogenously produced neurotrophins regulate survival and differentiation of cortical progenitors via distinct signaling pathways. J Neurosci 2003; 23: 5149-5160.
93. Ricard J, Salinas J, Garcia L, Liebl DJ. EphrinB3 regulates cell proliferation and survival in adult neurogenesis. Mol Cell Neurosci 2006; 31: 713-722.
94. Furne C, Ricard J, Cabrera JR, et al. EphrinB3 is an anti-apoptotic ligand that inhibits the dependence receptor functions of EphA4 receptors during adult neurogenesis. Biochim Biophys Acta 2009; 1793: 231-238.
95. Theus MH, Ricard J, Bethea JR, Liebl DJ. EphB3 limits the expansion of neural progenitor cells in the subventricular zone by regulating p53 during homeostasis and following traumatic brain injury. Stem Cells 2010; 28: 1231-1242.
96. Bernd P. The role of neurotrophins during early development. Gene Expr 2008; 14: 241-250.
97. Conover JC, Yancopoulos GD. Neurotrophin regulation of the developing nervous system: analyses of knockout mice. Rev Neurosci 1997; 8: 13-27.
98. Lykissas MG, Batistatou AK, Charalabopoulos KA, Beris AE. The role of neurotrophins in axonal growth, guidance, and regeneration. Curr Neurovasc Res 2007; 4: 143-151.
99. Royo NC, Conte V, Saatman KE, et al. Hippocampal vulnerability following traumatic brain injury: a potential role for neurotrophin-4/5 in pyramidal cell neuroprotection. Eur J Neurosci 2006; 23: 1089-1102.
100. Madathil SK, Evans HN, Saatman KE. Temporal and regional changes in IGF-1/IGF-1R signaling in the mouse brain after traumatic brain injury. J Neurotrauma 2010; 27: 95-107.
101. Conte V, Royo C, Shimizu S, et al. Neurotrophic factors Pathophysiology and Therapeutic Applications in Traumatic Brain Injury. Eur J Trauma 2003; 29: 335-355.
102. Johanson C, Stopa E, Baird A, Sharma H. Traumatic brain injury and recovery mechanisms: peptide modulation of periventricular neurogenic regions by the choroid plexus-CSF nexus. J Neural Transm 2011; 118: 115-133.
103. Hicks RR, Martin VB, Zhang L, Seroogy KB. Mild experimental brain injury differentially alters the expression of neurotrophin and neurotrophin receptor mRNAs in the hippocampus. Exp Neurol 1999; 160: 469-478.
104. Hicks RR, Li C, Zhang L, et al. Alterations in BDNF and trkB mRNA levels in the cerebral cortex following experimental brain trauma in rats. J Neurotrauma 1999; 16: 501-510.
105. Yang K, Perez-Polo JR, Mu XS, et al. Increased expression of brain-derived neurotrophic factor but not neurotrophin-3 mRNA in rat brain after cortical impact injury. J Neurosci Res 1996; 44: 157-164.
106. Blaha GR, Raghupathi R, Saatman KE, McIntosh TK. Brain-derived neurotrophic factor administration after traumatic brain injury in the rat does not protect againast behavioral or histological deficits. Neuroscience 2000; 99: 483-493.
107. Ma H, Yu B, Kong L, Zhang Y, Shi Y. Neural stem cells over-expressing brain-derived neurotrophic factor (BDNF) stimulate synaptic protein expression and promote functional recovery following transplantation in rat model of traumatic brain injury. Neurochem Res 2012; 37: 69-83.
108. Gao X, Chen J. Conditional knockout of brain-derived neurotrophic factor in the hippocampus increases death of adult-born immature neurons following traumatic brain injury. J Neurotrauma 2009; 26: 1325-1335.
109. Wu H, Lu D, Jiang H, et al. Simvastatin-mediated upregulation of VEGF and BDNF, activation of the PI3K/Akt pathway, and increase of neurogenesis are associated with therapeutic improvement after traumatic brain injury. J Neurotrauma 2008; 25: 130-139.
110. Yoshimura S, Teramoto T, Whalen MJ, et al. FGF-2 regulates neurogenesis and degeneration in the dentate gyrus after traumatic brain injury in mice. J Clin Invest 2003; 112: 1202-1210.
111. Dietrich WD, Alonso O, Busto R, Finklestein SP. Posttreatment with intravenous bFGF reduces histopathological damage following fluid-percussion brain injury in rats. J Neurotrauma 1996; 13: 309-316.
112. Yan HQ, Yu J, Kline AE, et al. Evaluation of combined fibroblast growth factor-2 and moderate hypothermia therapy in traumatically brain injured rats. Brain Res 2000; 887: 134-143.
113. McDermott KL, Raghupathi R, Fernandez SC, et al. Delayed administration of basic fibroblast growth factor attenuates cognitive dysfunction following parasagittal flui-percussion injury in the rat. J Neurotrauma 1997; 14: 191-200.
114. Sun D, Bullock MR, McGinn MJ, et al. Basic fibroblast growth factor-enhanced neurogenesis contributes to cognitive recovery in rats following traumatic brain injury. Exp Neurol 2009; 216: 56-65.
115. Buchli AD, Schwab ME. Inhibition of Nogo: a key strategy to increase regeneration, plasticity and functional recovery of the lesioned central nervous system. Ann Med 2005; 37: 556-567.
116. Fitch MT, Silver J. CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure. Exp Neurol 2008; 209: 294-301.
117. Liebscher T, Schnell L, Schnell D, et al. Nogo-A antibody improves regeneration and locomotion of spinal cord-injured rats. Ann Neurol 2005; 58: 706-719.
118. Seymour AB, Andrews EM, Tsai SY, et al. Delayed treatment with monoclonal antibody IN-1 1 week after stroke results in recovery of function and corticorubral plasticity in adult rats. J Cereb Blood Flow Metab 2005; 25: 1366-1375.
119. Marklund N, Morales D, Clausen F, et al. Functional outcome is impaired following traumatic brain injury in aging Nogo-A/B-deficient mice. Neuroscience 2009; 163: 540-551.
120. Lenzlinger PM, Shimizu S, Marklund N, et al. Delayed inhibition of Nogo-A does not alter injury-induced axonal sprouting but enhances recovery of cognitive function following experimental traumatic brain injury in rats. Neuroscience 2005; 134: 1047-1056.
121. Hanell A, Clausen F, Bjork M, et al. Genetic deletion and pharmacological inhibition of Nogo-66 receptor impairs cognitive outcome after traumatic brain injury in mice. J Neurotrauma 2010; 27: 1297-1309.
122. Omoto S, Ueno M, Mochio S, Takai T, Yamashita T. Genetic deletion of paired immunoglobulin-like receptor B does not promote axonal plasticity or functional recovery after traumatic brain injury. J Neurosci 2010; 30: 13045-13052.